Newsletter | September 14, 2024

09.14.24 -- Bioprocess Online Best Of August

AUGUST'S BEST FEATURED EDITORIAL

9 Common Tech Transfer Pitfalls To Avoid

Many issues can trip up a tech transfer process. Here are nine of them— plus ways to mitigate each.

Improving Viral Safety: Highlights Of ICH Q5A(R2), USP, Ph. Eur. Recommendations

ICH Q5A (R2) was released in Nov. 2023 and adopted by the FDA and EMA earlier this year. For a fuller assessment of viral control, compendia from the USP and European Pharmacopeia help.

Bacterial Endotoxin Testing, Part 4: Key Tests For Endotoxin Detection

This article concludes the author's series on bacterial endotoxin testing. It discusses best practices for the labeled lysate sensitivity test, non-interfering dilution determination, and more.

AUGUST'S BEST INDUSTRY INSIGHTS

Overcoming Bispecific Antibody Purification Challenges

Enhance the quality and safety of your BsAb therapeutics with a highly efficient with the right chromatography hydroxyapatite media.

The High Cost Of Going Cheap

Developers often aim to cut expenses during development. Discover the long-term outcomes of cost-effective measures like using RUO leukopaks compared to investing in high-quality GMP-grade vectors.

Benefit From Leveraging Perfusion Early In Process Development

By addressing the complex needs of cell culture from the start, organizations can take steps to optimize their process, ensuring they are maximizing productivity and product quality.

AUGUST'S BEST SOLUTIONS

STELLARIS DLS Digital Light Sheet Microscope

Should You Digitalize Your CQV Process?

Commissioning, Qualification, Regulatory Compliance Services

Connect With Bioprocess Online: